This inventor holds 1 USPTO granted patent. Top assignee: Fresenius Kabi Deutschland Gmbh. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Matteo Costioli: Innovator in Antibody Purification
Introduction
Matteo Costioli is a prominent inventor based in Lausanne, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the purification of antibodies. His innovative work has the potential to enhance the production and quality of therapeutic antibodies.
Latest Patents
Matteo holds a patent for "Methods of purifying and producing an adalimumab antibody." This invention relates to a method for purifying adalimumab or a biosimilar from a sample containing both the antibody and impurities. The process utilizes hydroxyapatite resin in a Bind/Elute mode, ensuring that the adalimumab binds to the resin while impurities remain unbound. Additionally, the invention includes pharmaceutical compositions of the purified adalimumab and the adalimumab obtainable through this process.
Career Highlights
Matteo is currently employed at Fresenius Kabi Deutschland GmbH, where he continues to advance his research in antibody purification. His work is crucial in the development of effective therapeutic solutions in the pharmaceutical industry.
Collaborations
Matteo collaborates with notable colleagues, including Harry-james Sutter and Hervé Broly. Their combined expertise contributes to the innovative projects at Fresenius Kabi.
Conclusion
Matteo Costioli's contributions to the field of biotechnology, particularly in antibody purification, highlight his role as an influential inventor. His patent on adalimumab purification methods showcases his commitment to advancing therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile